Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill’s relationship with Japan’s RIKEN institute.
CIHR and AMED support our project to develop new epigenomics techniques to study trained immunity!
Commentaires